FDA Clears AI-Powered Skin Cancer Detection Device
DermaSensor Inc. announced FDA clearance for its real-time, non-invasive skin cancer evaluation system which detects common skin cancers.
Read MorePosted by Andy Lundin | Jan 26, 2024 | Melanoma |
DermaSensor Inc. announced FDA clearance for its real-time, non-invasive skin cancer evaluation system which detects common skin cancers.
Read MorePosted by Andy Lundin | Jan 25, 2024 | Digital Pathology |
New research has led to the U.K. government approving the use of digital pathology to help speed up the analysis of cancer screening samples.
Read MorePosted by Andy Lundin | Jan 24, 2024 | Cancer |
Researchers developed a new machine-learning tool that could enable earlier cancer detection in patients via smaller blood draws
Read MorePosted by Andy Lundin | Jan 24, 2024 | Diagnostic Technologies |
New software combines AI and machine learning to measure the significance of specific genomic biomarkers to predict diseases in individuals.
Read MorePosted by Chris Wolski | Jan 19, 2024 | Middleware & Software |
Low-code LIMS offer an adaptable, nimble platform, facilitating quick customization to cater to the specific, individualized needs of a lab.
Read More